Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 156 entries
View as:

A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

Phase: N/A Priority: Normal
NCT ID: NCT01485770 Org: User:
Start: 12/31/11 End: 05/31/12 Due: 05/31/13

Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor

Phase: N/A Priority: Normal
NCT ID: NCT00598078 Org: User:
Start: 12/31/07 End: 12/31/08 Due: 12/31/09

Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04592159 Org: User:
Start: 02/01/21 End: 03/31/23 Due: 03/31/24

A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity

Phase: N/A Priority: Normal
NCT ID: NCT03954106 Org: User:
Start: 10/04/19 End: 09/30/20 Due: 09/30/21

A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

Phase: N/A Priority: Normal
NCT ID: NCT02221869 Org: User:
Start: 10/01/14 End: 01/25/19 Due: 01/25/20

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"

Phase: N/A Priority: Normal
NCT ID: NCT02348593 Org: User:
Start: 05/31/15 End: 02/28/17 Due: 02/28/18

Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT00066170 Org: User:
Start: 04/30/03 End: 11/30/04 Due: 11/30/05

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01361607 Org: User:
Start: 05/27/11 End: 11/24/14 Due: 11/24/15

A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT02607891 Org: User:
Start: 11/09/16 End: 10/02/18 Due: 10/02/19

A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT01606202 Org: User:
Start: 07/31/02 End: 01/31/05 Due: 01/31/06

A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05642442 Org: User:
Start: 12/01/22 End: 11/11/24 Due: 11/11/25

A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT04803786 Org: User:
Start: 04/09/21 End: 02/24/22 Due: 02/24/23

A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00710424 Org: User:
Start: 07/31/05 End: 06/30/06 Due: 06/30/07

A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA

Phase: N/A Priority: Normal
NCT ID: NCT04291937 Org: User:
Start: - End: - Due: -

Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain

Phase: N/A Priority: Normal
NCT ID: NCT00675948 Org: User:
Start: 04/30/02 End: 09/30/06 Due: 09/30/07

"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"

Phase: N/A Priority: Normal
NCT ID: NCT02348632 Org: User:
Start: 05/31/15 End: 12/31/17 Due: 12/31/18

Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT06113237 Org: User:
Start: 07/30/25 End: 08/31/33 Due: 08/31/34

Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients

Phase: N/A Priority: Normal
NCT ID: NCT01887301 Org: User:
Start: 07/31/13 End: 05/31/14 Due: 05/31/15

A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT05869773 Org: User:
Start: 06/26/23 End: 03/10/25 Due: 03/10/26

Phase I Study of mPEG-R-Crisantaspase Given IV

Phase: N/A Priority: Normal
NCT ID: NCT01551524 Org: User:
Start: 03/31/12 End: 02/28/15 Due: 02/28/16

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

Phase: N/A Priority: Normal
NCT ID: NCT05485831 Org: User:
Start: 02/24/25 End: 01/31/26 Due: 01/31/27

Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01696084 Org: User:
Start: 12/13/12 End: 12/31/15 Due: 12/31/16

Experimental Medication For the Treatment of Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00097708 Org: User:
Start: 11/30/04 End: 12/31/05 Due: 12/31/06

Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00702468 Org: User:
Start: 11/30/07 End: 01/31/09 Due: 01/31/10

A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02053272 Org: User:
Start: 02/28/14 End: 02/29/16 Due: 02/28/17